MedicationsVet-Reviewed

Numelvi vs Apoquel: How the Two JAK Inhibitors Compare for Itchy Dogs

Numelvi and Apoquel are both prescription JAK inhibitor tablets for allergic itch in dogs, but they differ in age limits, dosing, and cost. This side-by-side guide shows the differences and where Zenrelia and Cytopoint fit.

15 min read

Medically reviewed by Dr. Pippa Elliott, BVMS MRCVS · Last reviewed

A veterinarian talking with an owner across an exam table while a white Samoyed sits between them

Numelvi· atinvicitinib

Numelvi (atinvicitinib) is a once-daily prescription tablet from Merck Animal Health, FDA-approved (NADA 141-596) to control itch from allergic dermatitis in dogs 6 months and older. It is a selective JAK1 inhibitor given with food.

Janus kinase (JAK) inhibitor, selective JAK1Prescription (Rx)Dogs
A dog on the couch looking at a phone video call with a veterinarian
DutchSponsored

Is Numelvi right for your dog?

A licensed vet at Dutch can assess your dog over video and prescribe treatment when it's appropriate, delivered to your door.

Use code Pets60

I need a prescription

Plans start at $12/month · covers up to 5 pets

  • Licensed vets in most states
  • Rx for 150+ conditions
  • 4.7 on Trustpilot

Numelvi vs Apoquel is a choice between two prescription JAK inhibitor tablets that control itch from allergic dermatitis in dogs. Numelvi (atinvicitinib, from Merck Animal Health) is labeled for dogs 6 months and older, while Apoquel (oclacitinib, from Zoetis) is labeled for dogs at least 12 months old, per the FDA labels on DailyMed for Numelvi and Apoquel.

Both need a veterinarian's prescription, so a dog with ongoing allergic itch needs a vet visit before either one is an option. No head-to-head trial of Numelvi vs Apoquel has been published, so the vet chooses based on the dog's age, health history, dosing schedule, and cost rather than on a proven winner.

Numelvi vs Apoquel at a glance: how the two JAK inhibitors differ and which may fit your dog

FactorNumelviApoquel
Active ingredient and makerAtinvicitinib, Merck Animal HealthOclacitinib maleate, Zoetis
FDA approvalNADA 141-596, announced in February 2026NADA 141-345, approved January 20, 2014
Minimum age6 months and older12 months and older
Lowest label weight band4.4 lb (2 kg)6.6 lb (3.0 kg)
Dosing scheduleOnce daily with food from day oneTwice daily for up to 14 days, then once daily, with or without food
Onset stated by maker2 to 4 hours (Merck, itch model study)As little as 4 hours (Zoetis, flea allergy model study)
Infection cautionNot for dogs with serious infections; may raise risk of demodicosis and interdigital furunculosisNot for dogs with serious infections; may raise infection risk
Cancer cautionNew tumors reported with other JAK inhibitorsNew tumors seen in clinical studies and after approval
Monthly costVaries by weight band; 21.6 mg, 30 tablets listed at $84 on Chewy (November 2026)Varies by weight band; 16 mg, 30 tablets listed at $94.86 on Chewy (November 2026)
Key Takeaways
  • 1Both are prescription Janus kinase (JAK) inhibitor tablets for allergic itch, and how each drug blocks itch signals differs mainly in JAK1 selectivity.
  • 2Numelvi is labeled from 6 months of age; Apoquel is labeled from 12 months.
  • 3The dosing schedule differences show up early: Numelvi is once daily with food from the start, while Apoquel begins twice daily for up to 14 days.
  • 4No head-to-head trial exists, so your vet weighs age, health history, infection or cancer risk, and monthly cost.

Two label facts drive most decisions for dogs. The minimum age separates young dogs from adults, and the dosing schedule differs during the first two weeks, when Apoquel is given twice a day. The onset figures each maker publishes come from different study models, so they are not a direct race.

Both labels share the core JAK-class cautions: neither drug is for dogs with serious infections, and both warn about infections and new tumors. On Numelvi vs Apoquel side effects, vomiting and diarrhea appear among the most frequent problems for both. The wider range of dog allergy medicine includes non-JAK options a vet may weigh too.

Numelvi is the newer drug. Merck announced its FDA approval in a Merck news release in February 2026, describing it as a second-generation JAK inhibitor. Like Apoquel, it is filled by a veterinary clinic or by Chewy Pharmacy only with a veterinarian's prescription.

Numelvi (atinvicitinib) Tablets for Dogs, 21.6-mg, 30 Tablets
From ChewyIn stock
Numelvi (atinvicitinib) Tablets for Dogs, 21.6-mg, 30 Tablets

Once-daily Numelvi 21.6 mg tablets for allergic itch in dogs 6 months and older, filled with a vet's prescription.

$84

Webvet may earn a commission when you click through to Chewy, at no extra cost to you.

Apoquel has the longer track record. Its label covers control of atopic dermatitis as well as itch from allergic dermatitis, and its continuation study followed dogs for a mean of 372 days. Either drug is one part of managing dog skin allergies, alongside whatever the vet finds driving the itch.

Is Numelvi more effective than Apoquel?

No published study shows that Numelvi works better than Apoquel, or the reverse, because the two have never been tested against each other. Each was compared only with a placebo in its own field study, and those studies defined success differently, so their percentages cannot be lined up as a contest.

For context, the Numelvi label reports an estimated treatment success rate of 0.23 versus 0.07 for placebo, using a strict bar of at least a 50% drop in owner-scored itch on 5 of the first 7 days.

The Apoquel label reports that 86.4% of treated dogs versus 42.5% on placebo had a 2 cm drop on a 10 cm owner itch scale after one week.

How Numelvi and Apoquel work: JAK1 selectivity, onset, and daily dosing

Itch and skin inflammation in allergic dogs depend on signaling proteins called cytokines, and many of those cytokines need Janus kinase (JAK) enzymes to send their message. Both drugs block that JAK step, which is how each drug blocks itch signals. Neither is a corticosteroid or an antihistamine, according to both labels.

A cream-colored labradoodle scratching its side with a hind leg on a sunny backyard lawn
A labradoodle scratches its side on a sunny backyard lawn.

The difference lies in which JAK enzymes each drug favors. The Numelvi label says atinvicitinib is more selective for JAK1 than for JAK2, JAK3, and TYK2. Merck adds a manufacturer claim that it is at least 10 times more selective for JAK1 in laboratory assays, which is where the second-generation label comes from.

The Apoquel label describes oclacitinib as blocking allergy cytokines that depend on JAK1 or JAK3, with little effect on JAK2-dependent cytokines involved in making blood cells. That label does not use the word selectivity. More on how oclacitinib behaves over months of use is in oclacitinib for dogs.

Apoquel (oclacitinib) TABLETS for Dogs, 16-mg, 30 tablets
From ChewyIn stock
Apoquel (oclacitinib) TABLETS for Dogs, 16-mg, 30 tablets

Apoquel 16 mg oral tablets to relieve allergic itch in dogs, dispensed only with your veterinarian's prescription.

$94.86

Webvet may earn a commission when you click through to Chewy, at no extra cost to you.

Whether greater JAK1 selectivity makes a practical difference for an individual dog has not been shown in a direct comparison. What owners notice day to day are the dosing schedule differences:

  • Numelvi: one dose a day, given with food at or around mealtime, per the Merck Animal Health Numelvi page. Food matters here: the label reports peak blood levels 280% higher and total exposure 120% higher when the tablet was given fed rather than fasted.
  • Apoquel: twice a day for up to 14 days, then once a day for maintenance, with or without food, per the Apoquel label.
  • How long each lasts: the labels give a half-life of 2.3 hours for atinvicitinib and 4.1 hours for oclacitinib, and VCA Animal Hospitals describes both as short-acting drugs that stop working within 24 hours.

Apoquel tablets come in 3.6 mg, 5.4 mg, and 16 mg strengths, and the 16 mg size covers the larger weight bands. As a prescription drug, it is dispensed by the clinic or by Chewy Pharmacy only after a veterinarian authorizes it.

Because both drugs are short-acting, the daily routine matters. The owner gives exactly what the vet prescribed and never changes or stops the dose without the vet's advice.

How long does it take for Numelvi to kick in?

Merck states that Numelvi is absorbed quickly and starts relieving allergic itch within 2 to 4 hours, based on a study model in which itch was triggered on purpose. The VCA atinvicitinib page gives the same 2 to 4 hours but notes that full effects may not be noticeable right away.

Sources disagree on Apoquel's onset. Zoetis says it starts relieving itch in as little as 4 hours, based on a flea allergy model study. The VCA oclacitinib page says it should take effect within one to two days, and the Merck Veterinary Manual lists onset within 24 hours.

Numelvi vs Apoquel dosage for dogs by weight

Label weight bandLabel doseTablet strength
Numelvi 4.4 - 6.5 lb (2 - 2.9 kg)0.5 tablet once daily with food4.8 mg tablet
Numelvi 6.6 - 9.5 lb (3 - 4.3 kg)0.5 tablet once daily with food7.2 mg tablet
Numelvi 9.6 - 13.3 lb (4.4 - 6 kg)1 tablet once daily with food4.8 mg tablet
Numelvi 13.4 - 19.9 lb (6.1 - 9 kg)1 tablet once daily with food7.2 mg tablet
Numelvi 20 - 29.8 lb (9.1 - 13.5 kg)0.5 tablet once daily with food21.6 mg tablet
Numelvi 29.9 - 42.6 lb (13.6 - 19.3 kg)0.5 tablet once daily with food31.6 mg tablet
Numelvi 42.7 - 58.4 lb (19.4 - 26.5 kg)1 tablet once daily with food21.6 mg tablet
Numelvi 58.5 - 87 lb (26.6 - 39.5 kg)1 tablet once daily with food31.6 mg tablet
Numelvi 87.1 - 118.9 lb (39.6 - 54 kg)1.5 tablets once daily with food31.6 mg tablet
Numelvi 119 - 174.2 lb (54.1 - 79 kg)2 tablets once daily with food31.6 mg tablet
Numelvi 174.3 lb and over (79.1 kg and over)appropriate combination of tablet strengthscombination
Apoquel 6.6 - 9.9 lb (3.0 - 4.4 kg)0.5 tablet twice daily up to 14 days, then once daily3.6 mg tablet
Apoquel 10.0 - 14.9 lb (4.5 - 5.9 kg)0.5 tablet, same schedule5.4 mg tablet
Apoquel 15.0 - 19.9 lb (6.0 - 8.9 kg)1 tablet, same schedule3.6 mg tablet
Apoquel 20.0 - 29.9 lb (9.0 - 13.4 kg)1 tablet, same schedule5.4 mg tablet
Apoquel 30.0 - 44.9 lb (13.5 - 19.9 kg)0.5 tablet, same schedule16 mg tablet
Apoquel 45.0 - 59.9 lb (20.0 - 26.9 kg)2 tablets, same schedule5.4 mg tablet
Apoquel 60.0 - 89.9 lb (27.0 - 39.9 kg)1 tablet, same schedule16 mg tablet
Apoquel 90.0 - 129.9 lb (40.0 - 54.9 kg)1.5 tablets, same schedule16 mg tablet
Apoquel 130.0 - 175.9 lb (55.0 - 80.0 kg)2 tablets, same schedule16 mg tablet

Each label assigns a tablet strength and count to every weight band. Numelvi's label dose is 0.36 to 0.54 mg/lb (0.8 to 1.2 mg/kg) once daily with food; Apoquel's is 0.18 to 0.27 mg/lb (0.4 to 0.6 mg/kg), twice daily for up to 14 days, then once daily.

These are the ranges vets work within when they write the prescription, not a chart for owners to dose from. The owner gives exactly the tablet count the vet prescribed, and never changes the amount, splits tablets differently, or stops the drug without talking to the vet first.

The weight bands do not line up between the two drugs, as two examples from the labels show:

  • A 50 lb dog: Numelvi's 42.7 to 58.4 lb band directs one 21.6 mg tablet; Apoquel's 45.0 to 59.9 lb band directs two 5.4 mg tablets.
  • A 25 lb dog: Numelvi's 20 to 29.8 lb band directs half a 21.6 mg tablet; Apoquel's 20.0 to 29.9 lb band directs one 5.4 mg tablet.
Two veterinary staff members steadying a Boston terrier sitting on a clinic exam table
Two veterinary staff members steady a Boston terrier on the exam table.

A few practical differences come from the labels themselves:

  • Tablet strengths: Numelvi comes in 4.8 mg, 7.2 mg, 21.6 mg, and 31.6 mg scored tablets; Apoquel tablets come in 3.6 mg, 5.4 mg, and 16 mg, also scored.
  • Bottle sizes: each Numelvi strength comes in 30 and 90 count bottles; the Apoquel label lists 100 and 250 count bottles, while pharmacies may dispense smaller counts.
  • Food: Numelvi is given with food, while Apoquel and Apoquel Chewable can be given with or without food.
  • Half tablets: several weight bands on both labels call for half a tablet, so a dog in one of those bands uses a bottle more slowly than a dog taking whole tablets.
  • Very large dogs: dogs of 174.3 lb and over get a combination of Numelvi strengths chosen by the vet; Apoquel's chart ends at 175.9 lb.

Apoquel also comes as a chewable tablet. Zoetis describes Apoquel Chewable as a pork-liver flavored chewable that can be given with or without food, in three strengths. The 16 mg chewable is a prescription product, and Chewy Pharmacy fills it only with a veterinarian's prescription, the same as the standard tablet.

Whichever drug the vet chooses, a consistent time each day makes it easier to keep up with a once-daily or twice-daily routine. Linking the dose to a meal or a walk helps many households avoid missed or doubled tablets.

Numelvi has no chewable form, so owners of picky dogs often hide the tablet. Because Merck directs giving Numelvi at or around mealtime, a treat pouch can simply be offered with the meal. Greenies Pill Pockets Cheese Flavor, Tablet Size are cheese-flavored treats with a built-in pouch that holds most small tablets.

Greenies Pill Pockets Cheese Flavor Natural Dog Treats, Tablet Size, 30 count
From ChewyIn stock
Greenies Pill Pockets Cheese Flavor Natural Dog Treats, Tablet Size, 30 count

Cheese-flavored Greenies Pill Pockets with a built-in pouch that holds most small tablets, for easier pill time.

$11.99

Webvet may earn a commission when you click through to Chewy, at no extra cost to you.

Age limits and dogs that should not take either drug

The biggest label difference is the minimum age for each drug. Numelvi is not for use in dogs less than 6 months old, while Apoquel is not for use in dogs less than 12 months old.

Merck states Numelvi is the only JAK inhibitor approved for dogs as young as six months, making it the JAK option for dogs between 6 and 12 months old.

A veterinarian listening to the chest of a yellow Labrador puppy sitting on an exam table
A veterinarian listens to a young Labrador puppy's chest during an exam.

Beyond age, the labels and VCA list dogs that should not get these drugs, or that need a careful risk discussion first:

  • Serious infections: both labels say not for use in dogs with serious infections.
  • Breeding, pregnant, or nursing dogs: Apoquel is not for use in breeding dogs or pregnant or lactating females. Numelvi's safe use has not been evaluated in these dogs, and a laboratory safety study found decreased average testes weight.
  • Recurrent demodicosis: both labels ask the vet to weigh risks and benefits first; the Apoquel label adds a history of recurrent serious infections or neoplasia.
  • Cancer history: VCA says not to use oclacitinib in pets with cancer or a history of cancer, and lists dogs with severe infections or neoplasia among those that should not receive atinvicitinib.
  • Very small dogs: VCA lists dogs under 4.4 lb (2 kg) for atinvicitinib, which matches where the Numelvi weight chart begins; Apoquel's chart starts at 6.6 lb.
  • Other immune-suppressing drugs: safe use alongside glucocorticoids, cyclosporine, or other systemic immunosuppressants has not been evaluated for either drug.

VCA's wording on neoplasia is broader than the Numelvi label, which presents tumors as a JAK-class warning rather than a firm do-not-use. That gap is worth raising with the vet for any dog with a lump, a past tumor, or a recurring skin infection.

A golden retriever beside its pet parent, who is on a phone video call with a veterinarian
DutchSponsored

Vet care that's always there

Unlimited video calls and messaging with licensed vets for less than a typical vet visit. One membership covers up to five pets.

Use code Pets60

I need a prescription

Plans start at $12/month · covers up to 5 pets

  • Licensed vets in most states
  • Rx for 150+ conditions
  • 4.7 on Trustpilot

Side effects of Numelvi vs Apoquel

Apoquel Chewable contains the same active ingredient as the tablet. Its Chewy listing names vomiting and diarrhea as the most common side effects and notes it has been used safely with many common medications, including parasiticides, antibiotics, and vaccines. Like the tablet, it is filled only with a veterinarian's prescription.

Apoquel (oclacitinib CHEWABLE tablet) CHEWABLE for Dogs, 16mg, 30 tablets
From ChewyIn stock
Apoquel (oclacitinib CHEWABLE tablet) CHEWABLE for Dogs, 16mg, 30 tablets

Apoquel Chewable 16 mg, an oral chewable form of oclacitinib for allergic itch in dogs; requires a vet's prescription.

$89.70

Webvet may earn a commission when you click through to Chewy, at no extra cost to you.

Both drugs were generally well tolerated in their field studies, and the most common problems were stomach-related. Because each study used its own design and length, the figures describe each drug against its own placebo group rather than against each other:

  • Numelvi (28-day study, 144 dogs per group): vomiting or nausea in 6.9% versus 4.2% on placebo, ear inflammation (otitis externa) in 6.3% versus 5.6%, and diarrhea in 4.2% versus 10.4% on placebo.
  • Apoquel (atopic dermatitis study, days 0 to 16): diarrhea in 4.6% versus 3.4%, vomiting in 3.9% versus 4.1%, appetite loss in 2.6% versus 0%, and lethargy in 2.0% versus 1.4%.
  • Apoquel over longer use: among 283 dogs on Apoquel, reported signs included skin infection (pyoderma) and unspecified skin lumps in 12.0% each, ear inflammation in 9.9%, vomiting in 9.2%, diarrhea in 6.0%, and histiocytoma in 3.9%.
  • Lab changes: the Numelvi label lists lower white blood cell counts, raised liver enzymes (ALT and AST), raised SDMA, and high cholesterol as likely drug-related changes.

Only three Numelvi dogs left the field study for an adverse reaction, two of them for diarrhea likely related to the drug. Numelvi's full side effect list and what is known about long-term use are covered in Numelvi for dogs; its label notes that safety has not been evaluated in a field study beyond 28 days.

The Numelvi label says it may increase susceptibility to opportunistic infections, including demodicosis and interdigital furunculosis, and notes new tumors reported with other JAK inhibitors; VCA adds that these cancers have not been seen in atinvicitinib trials. The Apoquel label reports new benign and malignant tumors in clinical studies and after approval.

Does Numelvi make dogs sleepy?

Sleepiness is not a common Numelvi effect. In the label's 28-day field study, lethargy was reported in 3.5% of dogs on Numelvi and the same 3.5% of dogs on placebo, and the label does not list drowsiness or somnolence. Apoquel's label shows lethargy in 2.0% of treated dogs versus 1.4% on placebo.

Ordinary tiredness and severe weakness are different things. Severe lack of energy, weakness, or pale gums on atinvicitinib is on VCA's list of rare reactions that call for contacting the vet immediately.

When to stop either drug and call the vet

These warning signs come from the VCA atinvicitinib page and the VCA oclacitinib page. For oclacitinib, VCA says to stop giving the drug and contact the veterinarian immediately if a skin mass, fever, shortness of breath, or other signs of infection develop.

Accidental overdose is a real risk with tablets left within reach. Both labels say to keep tablets in a secure place out of reach of dogs, cats, and other animals. The Merck Veterinary Manual notes that acute kidney injury is possible with toxic doses of oclacitinib.

A few other safety points apply in the home:

  • Human contact: the Numelvi label says to wash hands with soap and water right after handling tablets, and to seek medical attention immediately if a person swallows one.
  • Other changes: VCA advises watching for any abnormal changes at home on atinvicitinib; if any occur, stop giving atinvicitinib and contact the veterinarian.
  • Routine dosing: outside these warning signs, keep giving exactly what the vet prescribed and do not stop or change the dose without the vet.

Numelvi vs Apoquel cost per month

No manufacturer publishes a monthly price for either drug, and the monthly cost of each depends on the dog's weight band, how many tablets a day the vet prescribes, and where the prescription is filled. Listed pharmacy prices give a starting point for the conversation.

A man reads a printed invoice at a wooden clinic counter while a Cavalier King Charles spaniel waits on the floor
A man reads a printed invoice at a wooden clinic counter while his Cavalier King Charles spaniel waits.

Here is what the common package sizes were listed at on Chewy when we checked in November 2026. Each is filled by Chewy Pharmacy only with a veterinarian's prescription:

  • Numelvi 21.6 mg tablets, 30 count: listed at $84 on Chewy. One whole 21.6 mg tablet a day is the label dose for dogs of 42.7 to 58.4 lb, so a 30-count bottle is a month's supply only for dogs taking one whole tablet daily.
  • Apoquel 16 mg tablets, 30 count: listed at $94.86 on Chewy. One 16 mg tablet is the label dose for dogs of 60.0 to 89.9 lb, and the twice-daily start means the first month uses more tablets than later months.
  • Apoquel Chewable 16 mg, 30 count: listed at $89.70 on Chewy, the same 16 mg strength in chewable form.

Those bottles do not cover the same dogs, so the two prices are not a like-for-like monthly comparison. The once-daily Numelvi schedule from day one versus Apoquel's twice-daily start is the clearest built-in cost difference, mainly in the first two weeks.

Half-tablet weight bands stretch a bottle further, while dogs needing one and a half or two tablets go through it faster. Bloodwork the vet may run before or during treatment also adds to the overall cost. A closer look at Numelvi's price by tablet strength is in Numelvi for dogs.

Numelvi vs Zenrelia vs Apoquel: where the third JAK inhibitor fits

Zenrelia (ilunocitinib, from Elanco) is the third JAK inhibitor tablet for allergic itch in dogs. The Zenrelia FDA label on DailyMed shows approval under NADA 141-585, dated September 19, 2024, for dogs at least 12 months old, dosed at 0.6 to 0.8 mg/kg once daily with or without food.

For dogs, Numelvi vs Zenrelia differs in three main ways:

  • Age: Zenrelia and Apoquel both start at 12 months, as the Merck Veterinary Manual also notes; Numelvi starts at 6 months.
  • JAK selectivity: the Zenrelia label calls ilunocitinib a non-selective JAK inhibitor with high potency for JAK1, JAK2, and TYK2, while Numelvi is labeled as more selective for JAK1.
  • Vaccines: Zenrelia carries a boxed warning about inadequate vaccine response. Its label says to stop Zenrelia at least 28 days to 3 months before vaccination and withhold it for at least 28 days after.

Numelvi's label reports that dogs given three times the maximum dose for 84 days all had an adequate immune response to core and rabies vaccines, and Merck says there is no need to adjust a dog's vaccination routine on Numelvi. For a dog due for vaccines, that difference shapes where Zenrelia fits in the Numelvi vs Apoquel vs Zenrelia choice.

Zenrelia shares the once-daily convenience and, per Elanco, is labeled for dogs as small as 6.6 lb. No medicine is identical to Apoquel, but Numelvi and Zenrelia are the newest alternatives in the same JAK class, and other options are compared in Apoquel alternatives for dogs.

Numelvi vs Cytopoint: when an injection is the better fit

Cytopoint (lokivetmab) works on a different principle. It is a monoclonal antibody that, per a Zoetis news release, targets and neutralizes interleukin-31 (IL-31), a key protein that triggers itch. It is licensed by the USDA as a biologic rather than approved by the FDA as a drug.

A veterinarian giving an injection at the neck of a Shiba Inu while a staff member holds the dog
A veterinarian gives a Shiba Inu an injection while a staff member holds the dog.

The practical difference in Numelvi vs Cytopoint is daily tablets at home versus an injection at the clinic:

  • Schedule: Zoetis says one Cytopoint injection starts controlling allergic itch within one day and lasts 4 to 8 weeks, repeated as needed.
  • Age: Zoetis states Cytopoint is safe in dogs of any age, and the Merck Veterinary Manual lists no age restrictions or reported drug interactions.
  • Side effects: the Merck Veterinary Manual lists lethargy and stomach upset as the most common adverse effects.
  • Who gives it: the vet gives each injection in the office, so there are no pills to hide.

An injection can suit a dog that refuses tablets, an owner who struggles with a daily routine, or a puppy younger than Numelvi's 6-month minimum. Daily tablets can suit an owner who wants control at home and fewer clinic visits.

More detail is in Cytopoint for dogs and in the broader Apoquel vs Cytopoint comparison, which together round out Numelvi vs Apoquel vs Cytopoint.

Numelvi vs Apoquel questions

Frequently Asked Questions

Can a dog on Numelvi or Apoquel also take Benadryl?

Benadryl (diphenhydramine) is an antihistamine. VCA says oclacitinib can be safely combined with antihistamines. No primary source addresses giving diphenhydramine and Numelvi together, and antihistamines are not on Merck's list of medications used alongside Numelvi in its field trial, so ask the vet before giving the two together.

Can my dog switch from Apoquel to Numelvi?

A switch is possible only on a veterinarian's instructions. No published protocol covers moving from Apoquel to Numelvi, and Merck says the treatment plan should be discussed with the vet. Do not change drugs on your own; the veterinarian decides timing, weight band, and follow-up.

Can a puppy take Numelvi instead of Apoquel?

Yes, if the dog is at least 6 months old. Numelvi is labeled from 6 months of age, while Apoquel is not for dogs under 12 months, so a dog between those ages fits only the Numelvi label. Puppies under 6 months need a different option, such as Cytopoint, which Zoetis says is safe at any age.

Do Numelvi and Apoquel need blood work?

Often, yes. VCA says the vet may run baseline bloodwork before starting atinvicitinib and monitor bloodwork during treatment, and recommends periodic bloodwork monitoring for dogs on long-term oclacitinib. Both labels also call for monitoring for infections, and the Apoquel label for new tumors.

Can Numelvi or Apoquel be used with Cytopoint?

No primary source addresses giving Cytopoint together with Numelvi or Apoquel. Zoetis says the Cytopoint injection can be used in dogs on many other medications, and the Merck Veterinary Manual reports no drug interactions for lokivetmab. Whether to combine a JAK tablet with the injection is a decision for the vet.

Is Numelvi a generic version of Apoquel?

No. Numelvi's active ingredient is atinvicitinib, a selective JAK1 inhibitor made by Merck Animal Health, while Apoquel's is oclacitinib maleate, made by Zoetis. They are separate brand-name drugs with their own FDA approvals, labels, age limits, and dosing schedules.

Dr. Pippa Elliott

Veterinarian · BVMS MRCVS

Dr. Pippa Elliott, BVMS, MRCVS, is a veterinarian with nearly 30 years of experience in companion animal practice. Dr. Elliott earned her Bachelor of Veterinary Medicine and Surgery from the University of Glasgow. She was also designated a Member of the Royal College of Veterinary Surgeons. Married with 2 grown-up kids, Dr. Elliott has a naughty Puggle named Poggle, 3 cats and a bearded dragon.

Related reading